Creative Planning’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$20.9M Buy
434,104
+207,994
+92% +$9.7M 0.01% 423
2025
Q4
$11M Buy
226,110
+8,396
+4% +$416K 0.01% 578
2025
Q3
$10.3M Sell
217,714
-1,725
-0.8% -$83.3K 0.01% 547
2025
Q2
$10.6M Sell
219,439
-55,044
-20% -$2.81M 0.01% 502
2025
Q1
$15.2M Buy
274,483
+53,646
+24% +$2.9M 0.01% 376
2024
Q4
$10.7M Buy
220,837
+74
+0% +$3.76K 0.01% 426
2024
Q3
$12.7M Buy
220,763
+33,728
+18% +$1.82M 0.01% 371
2024
Q2
$9.07M Buy
187,035
+15,749
+9% +$760K 0.01% 442
2024
Q1
$8.32M Buy
171,286
+32,446
+23% +$1.58M 0.01% 456
2023
Q4
$6.9M Sell
138,840
-42,812
-24% -$2.09M 0.01% 480
2023
Q3
$9.74M Buy
181,652
+42,358
+30% +$2.26M 0.01% 357
2023
Q2
$7.51M Buy
139,294
+1,994
+1% +$107K 0.01% 411
2023
Q1
$7.47M Buy
137,300
+12,760
+10% +$621K 0.01% 401
2022
Q4
$6.03M Buy
124,540
+13,568
+12% +$596K 0.01% 441
2022
Q3
$4.22M Buy
110,972
+6,657
+6% +$297K 0.01% 476
2022
Q2
$5.22M Buy
104,315
+33,504
+47% +$1.78M 0.01% 440
2022
Q1
$3.63M Buy
70,811
+45,934
+185% +$2.37M 0.01% 534
2021
Q4
$1.25M Buy
24,877
+1,156
+5% +$57.2K ﹤0.01% 856
2021
Q3
$1.14M Buy
23,721
+5,035
+27% +$256K ﹤0.01% 885
2021
Q2
$984K Sell
18,686
-9,933
-35% -$518K ﹤0.01% 939
2021
Q1
$1.42M Sell
28,619
-7,516
-21% -$361K ﹤0.01% 867
2020
Q4
$1.76M Sell
36,135
-15,168
-30% -$748K ﹤0.01% 724
2020
Q3
$2.57M Buy
51,303
+3,385
+7% +$174K 0.01% 476
2020
Q2
$2.45M Buy
47,918
+19,422
+68% +$944K 0.01% 439
2020
Q1
$1.25M Buy
28,496
+2,064
+8% +$98.8K ﹤0.01% 563
2019
Q4
$1.33M Buy
26,432
+4,389
+20% +$206K ﹤0.01% 668
2019
Q3
$1.02M Sell
22,043
-839
-4% -$36.2K ﹤0.01% 747
2019
Q2
$990K Sell
22,882
-1,524
-6% -$64.8K ﹤0.01% 764
2019
Q1
$1.08M Sell
24,406
-2,764
-10% -$118K ﹤0.01% 707
2018
Q4
$1.18M Buy
27,170
+4,114
+18% +$181K ﹤0.01% 610
2018
Q3
$1.03M Sell
23,056
-6,520
-22% -$279K ﹤0.01% 752
2018
Q2
$1.18M Buy
29,576
+3,624
+14% +$143K ﹤0.01% 660
2018
Q1
$1.04M Sell
25,952
-3,785
-13% -$157K ﹤0.01% 719
2017
Q4
$1.28M Buy
29,737
+972
+3% +$44.8K 0.01% 601
2017
Q3
$1.43M Sell
28,765
-2,270
-7% -$110K 0.01% 563
2017
Q2
$1.49M Sell
31,035
-3,008
-9% -$144K 0.01% 532
2017
Q1
$1.54M Sell
34,043
-27,933
-45% -$1.18M 0.01% 515
2016
Q4
$2.51M Buy
61,976
+17,304
+39% +$682K 0.02% 341
2016
Q3
$1.71M Buy
44,672
+22,006
+97% +$883K 0.01% 425
2016
Q2
$949K Buy
22,666
+2,007
+10% +$82.3K 0.01% 538
2016
Q1
$830K Sell
20,659
-4,448
-18% -$179K 0.01% 555
2015
Q4
$1.07M Sell
25,107
-3,914
-13% -$180K 0.01% 486
2015
Q3
$1.38M Sell
29,021
-992
-3% -$50.5K 0.01% 389
2015
Q2
$1.49M Buy
30,013
+2,931
+11% +$149K 0.01% 367
2015
Q1
$1.34M Buy
27,082
+4,591
+20% +$219K 0.01% 374
2014
Q4
$1.03M Sell
22,491
-3,228
-13% -$157K 0.01% 440
2014
Q3
$1.45M Buy
25,719
+8,855
+53% +$476K 0.02% 309
2014
Q2
$897K Sell
16,864
-2,507
-13% -$133K 0.01% 424
2014
Q1
$1.01M Buy
19,371
+2,151
+12% +$109K 0.02% 366
2013
Q4
$924K Buy
17,220
+458
+3% +$23.6K 0.02% 330
2013
Q3
$849K Buy
16,762
+5,224
+45% +$266K 0.02% 305
2013
Q2
$594K Buy
+11,538
New +$615K 0.01% 366

Other funds holding SNY

Creative Planning's SNY Position: Q1 2026 in Review

Creative Planning increased its Sanofi (SNY) stake by 92% in Q1 2026, buying an estimated $9.7M and bringing the position to 434,104 shares worth $20.9M. The position accounts for 0.01% of the portfolio, ranked #423.

Creative Planning first reported a position in SNY in Q2 2013 and has held it in 52 quarters since. 737 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

  • Creative Planning held 434,104 shares of Sanofi worth $20.9M as of Q1 2026.
  • Creative Planning bought 207,994 Sanofi shares in Q1 2026, an estimated $9.7M.
  • Sanofi made up 0.01% of Creative Planning's portfolio in Q1 2026, its #423 holding.
  • Creative Planning first reported a position in Sanofi in Q2 2013 and has held it in 52 quarters since.
  • 737 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on Creative Planning's 13F filing for Q1 2026, filed 12 May 2026.